· Lynparza is the first and only approved PARPi targeting BRCA-mutated HER2-negative high-risk early breast cancer · New Data from OlympiA Phase…
Tokyo, September 23, 2020: Eisai Co., Ltd. announced that it has received a positive opinion from the European Medicines Agency…
Mumbai, September 23, 2020: Pharma major Lupin Limited (Lupin) announced the launch of Divalproex Sodium Extended-Release (ER) Tablets USP, 250 mg…
Ahmedabad September 18, 2020: Cadila Pharmaceuticals launches Obetocad in India, a generic version of Ocaliva® (Obeticholic Acid) primarily used for…
As Monotherapy for Partial-Onset Seizures, Pediatric Indication for Partial-Onset Seizures, as Well as New Formulation Tokyo, February 03, 2019: Eisai Co., Ltd.…
As Monotherapy for Partial-Onset Seizures, Pediatric Indication for Partial-Onset Seizures, as Well as New Formulation Tokyo, January 31, 2019: Eisai…
Mumbai, November 11, 2018: Eli Lilly and Company (India) Pvt. Ltd. (“Lilly India”) announced the launch of Olumiant™ (baricitinib). This…